Company Profile
Intract Pharma Limited
09610219•Private Limited With Share Capital
Get Full Access
27/05/2015
11 years
4
9
72110
low risk
Company Overview
Registration, classification & business activity
Intract Pharma Limited (09610219) is a private limited with share capital incorporated on 27/05/2015 (11 years old) and registered in cambridge, CB225EG. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Intract pharma is a biotechnology company innovating in the field of oral delivery of complex proteins such as monoclonal antibodies with a special focus on treatment of gastrointestinal and systemic immune-mediated inflammatory diseases. intract is applying it’s phloral and soteria technology platf...
Financial Overview
£1.48M
£196.4K
£1.29M
£2.32M
£1.35M
Key Metrics
9
Employees
4
Directors
5
Shareholders
13
Patents
Board of Directors
Innovate Grants
This company received a grant of £420330.0 for Development Of A Scalable Manufacturing Process For A Novel Oral Infliximab Product Using The Soteria Technology. The project started on 01/10/2018 and ended on 30/09/2021.
This company received a grant of £310302.0 for Ab-Biobetter. The project started on 01/01/2024 and ended on 31/12/2026.
Import / Export
Risk Assessment
low risk
International Score
Future Factor
excellent
Performance Rating